MTOR and glioblastoma: Our findings demonstrate that TDB exerts potent anti-GBM activity through multiple mechanisms, including inhibition of proliferation, induction of apoptosis, suppression of mTOR signaling, attenuation of epithelial–mesenchymal transition (EMT), and enhancement of temozolomide (TMZ) efficacy.